VVP
DGX icon

Venture Visionary Partners’s Quest Diagnostics DGX Stock Holding History

Venture Visionary Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$905K Buy
4,267
+1
+0% +$196 0.03% 361
2026
Q1 		$836K Sell
4,266
-13
-0.3% -$2.53K 0.03% 341
2025
Q4 		$743K Buy
4,279
+15
+0.4% +$2.73K 0.02% 366
2025
Q3 		$813K Hold
4,264
– – 0.03% 324
2025
Q2 		$766K Buy
4,264
+18
+0.4% +$3.13K 0.03% 323
2025
Q1 		$719K Hold
4,246
– – 0.03% 321
2024
Q4 		$641K Buy
4,246
+13
+0.3% +$2.02K 0.03% 321
2024
Q3 		$657K Hold
4,233
– – 0.03% 328
2024
Q2 		$580K Sell
4,233
-1
-0% -$137 0.03% 348
2024
Q1 		$564K Hold
4,234
– – 0.03% 350
2023
Q4 		$584K Buy
4,234
+1
+0% +$131 0.03% 333
2023
Q3 		$516K Hold
4,233
– – 0.03% 327
2023
Q2 		$595K Sell
4,233
-1
-0% -$138 0.04% 311
2023
Q1 		$599K Sell
4,234
-117
-3% -$16.7K 0.04% 309
2022
Q4 		$681K Buy
4,351
+1
+0% +$144 0.05% 273
2022
Q3 		$533K Hold
4,350
– – 0.04% 289
2022
Q2 		$579K Hold
4,350
– – 0.04% 271
2022
Q1 		$595K Hold
4,350
– – 0.04% 297
2021
Q4 		$752K Sell
4,350
-90
-2% -$13.7K 0.05% 264
2021
Q3 		$645K Buy
+4,440
New +$650K 0.05% 286
2021
Q2 		– Sell
-3,375
Closed -$433K – 502
2021
Q1 		$433K Sell
3,375
-1,043
-24% -$129K 0.04% 318
2020
Q4 		$526K Buy
4,418
+137
+3% +$16.7K 0.06% 226
2020
Q3 		$490K Buy
+4,281
New +$506K 0.12% 105

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Venture Visionary Partners's DGX Position: Q2 2026 in Review

Venture Visionary Partners increased its Quest Diagnostics (DGX) stake by 0.02% in Q2 2026, buying an estimated $196 and bringing the position to 4,267 shares worth $905K. The position accounts for 0.03% of the portfolio, ranked #361.

Venture Visionary Partners first reported a position in DGX in Q3 2020 and has held it in 23 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Venture Visionary Partners held 4,267 shares of Quest Diagnostics worth $905K as of Q2 2026.
  • Venture Visionary Partners bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
  • Quest Diagnostics made up 0.03% of Venture Visionary Partners's portfolio in Q2 2026, its #361 holding.
  • Venture Visionary Partners first reported a position in Quest Diagnostics in Q3 2020 and has held it in 23 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.